Literature DB >> 12556458

gamma-Secretase cleavage site specificity differs for intracellular and secretory amyloid beta.

Heike S Grimm1, Dirk Beher, Stefan F Lichtenthaler, Mark S Shearman, Konrad Beyreuther, Tobias Hartmann.   

Abstract

The final step in A beta generation is the cleavage of the C-terminal 99 amino acid residues of the amyloid precursor protein by gamma-secretase. gamma-Secretase activity is closely linked to the multi-transmembrane-spanning proteins presenilin 1 and presenilin 2. To elucidate whether the cleavage site specificities of gamma-secretase leading to the formation of secreted and intracellular A beta are identical, we made use of point mutations close to the gamma-cleavage site, known to have a dramatic effect on the 42/40 ratio of secreted A beta. We found that the selected point mutations only marginally influenced the 42/40 ratio of intracellular A beta, suggesting differences in the gamma-secretase cleavage site specificity for the generation of secreted and intracellular A beta. The analysis of the subcellular compartments involved in the generation of intracellular A beta revealed that A beta is not generated in the early secretory pathway in the human SH-SY5Y neuroblastoma cell line. In this study we identified late Golgi compartments to be involved in the generation of intracellular A beta. Moreover, we demonstrate that the presence of processed PS1 is not sufficient to obtain gamma-secretase processing of the truncated amyloid precursor protein construct C99, proposing the existence of an additional factor downstream of the endoplasmic reticulum and early Golgi required for the formation of an active gamma-secretase complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12556458     DOI: 10.1074/jbc.M210380200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Trafficking and proteolytic processing of APP.

Authors:  Christian Haass; Christoph Kaether; Gopal Thinakaran; Sangram Sisodia
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

2.  Vitamin E: Curse or Benefit in Alzheimer's Disease? A Systematic Investigation of the Impact of α-, γ- and δ-Tocopherol on Aß Generation and Degradation in Neuroblastoma Cells.

Authors:  M O W Grimm; C P Stahlmann; J Mett; V J Haupenthal; V C Zimmer; J Lehmann; B Hundsdörfer; K Endres; H S Grimm; T Hartmann
Journal:  J Nutr Health Aging       Date:  2015-06       Impact factor: 4.075

3.  Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.

Authors:  Haim Belinson; Dimitri Lev; Eliezer Masliah; Daniel M Michaelson
Journal:  J Neurosci       Date:  2008-04-30       Impact factor: 6.167

4.  Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.

Authors:  Marcus O W Grimm; Eva G Zinser; Sven Grösgen; Benjamin Hundsdörfer; Tatjana L Rothhaar; Verena K Burg; Lars Kaestner; Thomas A Bayer; Peter Lipp; Ulrike Müller; Heike S Grimm; Tobias Hartmann
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

5.  Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer's Disease.

Authors:  Marcus O W Grimm; Liesa Regner; Janine Mett; Christoph P Stahlmann; Pascal Schorr; Christopher Nelke; Olga Streidenberger; Hannah Stoetzel; Jakob Winkler; Shatha R Zaidan; Andrea Thiel; Kristina Endres; Heike S Grimm; Dietrich A Volmer; Tobias Hartmann
Journal:  Int J Mol Sci       Date:  2016-10-29       Impact factor: 5.923

6.  Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential.

Authors:  Markus Uhrig; Peter Brechlin; Olaf Jahn; Yuri Knyazev; Annette Weninger; Laura Busia; Kamran Honarnejad; Markus Otto; Tobias Hartmann
Journal:  BMC Med       Date:  2008-12-16       Impact factor: 8.775

7.  New Alzheimer amyloid beta responsive genes identified in human neuroblastoma cells by hierarchical clustering.

Authors:  Markus Uhrig; Carina Ittrich; Verena Wiedmann; Yuri Knyazev; Annette Weninger; Matthias Riemenschneider; Tobias Hartmann
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

8.  APP-BP1 inhibits Abeta42 levels by interacting with Presenilin-1.

Authors:  Yuzhi Chen; Angela M Bodles; Donna L McPhie; Rachael L Neve; Robert E Mrak; W Sue T Griffin
Journal:  Mol Neurodegener       Date:  2007-02-07       Impact factor: 14.195

Review 9.  Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.

Authors:  Sage C Arbor; Mike LaFontaine; Medhane Cumbay
Journal:  Yale J Biol Med       Date:  2016-03-24

Review 10.  β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.

Authors:  Botond Penke; Ferenc Bogár; Lívia Fülöp
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.